BA-Merrill Lynch 14/10/2010 1 Buy, Medium Risk $5.42 13.9%RBS Australia 14/10/2010 1 Buy $5.30 11.3%Credit Suisse 14/10/2010 3 Neutral $4.95 4.0%
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025